Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 4, 2023 (Week 44)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 13,144 32,999 1,255,605 1,412,574
New England 99 1,650 35,188 44,825
Connecticut - 430 1,155 10,493
Maine - 74 2,450 2,712
Massachusetts 15 687 23,997 24,234
New Hampshire - 82 2,269 2,408
Rhode Island 84 694 4,229 3,885
Vermont - 37 1,088 1,093
Middle Atlantic 1,650 4,176 164,996 164,098
New Jersey 34 789 28,946 28,425
New York (excluding New York City) 841 1,032 35,701 33,996
New York City - 1,498 54,980 54,858
Pennsylvania 775 1,231 45,369 46,819
East North Central 1,884 4,575 166,496 194,771
Illinois 80 1,811 44,185 60,628
Indiana 476 879 26,997 28,858
Michigan 277 912 28,135 36,583
Ohio 656 1,211 46,384 46,658
Wisconsin 395 562 20,795 22,044
West North Central 875 2,137 79,095 87,020
Iowa 130 333 11,508 12,609
Kansas 157 335 9,607 12,058
Minnesota 90 497 18,119 18,957
Missouri 497 746 27,130 27,488
Nebraska - 246 6,910 8,245
North Dakota 1 91 1,797 3,174
South Dakota - 125 4,024 4,489
South Atlantic 2,846 7,719 274,877 314,841
Delaware - 227 4,721 4,287
District of Columbia - 199 5,670 7,000
Florida 1,649 2,784 95,614 90,426
Georgia - 1,550 51,705 62,323
Maryland U NC U 26,058
North Carolina 14 1,445 49,891 55,246
South Carolina 489 774 28,099 30,635
Virginia 671 976 35,475 34,984
West Virginia 23 115 3,702 3,882
East South Central 1,276 2,452 79,150 94,968
Alabama 708 972 29,055 26,522
Kentucky 455 546 14,303 15,457
Mississippi 113 487 15,542 20,059
Tennessee - 1,094 20,250 32,930
West South Central 623 4,833 171,511 198,913
Arkansas 171 435 14,550 15,408
Louisiana 323 854 30,328 31,248
Oklahoma 4 473 13,062 17,532
Texas 125 3,152 113,571 134,725
Mountain 1,231 2,497 91,186 100,718
Arizona 450 873 33,963 35,235
Colorado 394 782 21,523 22,304
Idaho 51 148 4,819 5,058
Montana 62 92 2,794 3,558
Nevada 29 343 10,065 13,855
New Mexico 12 241 7,243 9,656
Utah 209 255 9,421 9,503
Wyoming 24 50 1,358 1,549
Pacific 2,660 5,049 193,106 212,420
Alaska 35 121 3,450 4,575
California 2,002 4,112 160,051 164,998
Hawaii - 132 - 4,718
Oregon 294 382 12,922 13,351
Washington 329 565 16,683 24,778
U.S. Territories - 105 1,138 4,011
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 105 1,138 4,011
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 5 45 126
Total 13,146 33,085 1,256,788 1,416,711
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.